KaloBios Pharmaceuticals Garners $17,000,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bdbe52f0-9ccc-4079-96df-dc98e7992107&Preview=1
Date
5/22/2012
Company Name
KaloBios Pharmaceuticals
Mailing Address
260 East Grand Avenue South San Francisco, CA 94080
Company Description
KaloBios is a vertically integrated therapeutic antibody company using its proprietary antibody engineering, humaneering and expression technologies for the development of a pipeline of antibody therapeutics.
Website
http://www.kalobios.com
Transaction Type
Venture Equity
Transaction Amount
$17,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed